Rare genetic diseases

biotechnical-servicesBy definition, rare genetic diseases affect less than 1 in 2000 people. These rare diseases seriously decrease the quality of life and currently there is no effective treatment to many of them. Historically, rare diseases were typically described as ‘syndromes’ or ‘diseases’ that received the name of the physician that first described the disease. Thanks to gene sequencing technologies, genetic mutations causing these diseases have been identified. Mouse models of rare genetic diseases provide an important tool to develop effective new therapies. Sylics offers preclinical testing in a range of mouse models of rare genetic diseases.